EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9

Anett Hudák, Matthew Roach, Dávid Pusztai, Aladár Pettkó-Szandtner, Annamária Letoha, László Szilák, Mimoun Azzouz, Tamás Letoha iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anett Hudák und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoidea Ltd., H-6726 Szeged, Hungary. Hauptthemen laut MEDLINE: Dependovirus, Syndecan-4. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, European Union, National Research, Development and Innovation Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their low pathogenicity, immunogenicity, and long-term gene expression, adeno-associated virus (AAV) vectors emerged as safe and efficient gene delivery tools, over-coming setbacks experienced with other viral gene delivery systems in early gene therapy trials. Among AAVs, AAV9 can translocate through the blood-brain barrier (BBB), making it a promising gene delivery tool for transducing the central nervous system (CNS) via systemic administration. Recent reports on the shortcomings of AAV9-mediated gene delivery into the CNS require reviewing the molecular base of AAV9 cellular biology. A more detailed understanding of AAV9’s cellular entry would eradicate current hurdles and enable more efficient AAV9-based gene therapy approaches. Syndecans, the transmembrane family of heparan-sulfate proteoglycans, facilitate the cellular uptake of various viruses and drug delivery systems. Utilizing human cell lines and syndecan-specific cellular assays, we assessed the involvement of syndecans in AAV9’s cellular entry. The ubiquitously expressed isoform, syndecan-4 proved its superiority in facilitating AAV9 internalization among syndecans. Introducing syndecan-4 into poorly transducible cell lines enabled robust AAV9-dependent gene transduction, while its knockdown reduced AAV9’s cellular entry. Attachment of AAV9 to syndecan-4 is mediated not just by the polyanionic heparan-sulfate chains but also by the cell-binding domain of the extracellular syndecan-4 core protein. Co-immunoprecipitation assays and affinity proteomics also confirmed the role of syndecan-4 in the cellular entry of AAV9. Overall, our findings highlight the universally expressed syndecan-4 as a significant contributor to the cellular internalization of AAV9 and provide a molecular-based, rational explanation for the low gene delivery potential of AAV9 into the CNS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusSyndecan-4HumansHeparan Sulfate ProteoglycansHeparan SulfateSulfatesSyndecan-1Syndecans

Stichwörter der Autor:innen

AAV9cellular entrygene deliveryheparan sulfate proteoglycanssyndecans

Substanzen

Heparan Sulfate ProteoglycansHeparan SulfateSulfatesSyndecan-1Syndecan-4SyndecansSDC4 protein, human

Autor:innen und Institutionen

  • Pharmacoidea Ltd., H-6726 Szeged, Hungary.
  • Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.
  • Biological Research Centre, Institute of Plant Biology, H-6726 Szeged, Hungary.
  • Albert Szent-Györgyi Clinical Center, Department of Medicine, Faculty of Medicine, University of Szeged, H-6726 Szeged, Hungary.
  • Szilák Laboratories Ltd., H-6725 Szeged, Hungary.

ORCID-Profile: Tamás Letoha

Förderung

  • Innovative Medicines Initiative
  • European Union
  • National Research, Development and Innovation Office
  • Innovative Medicines Initiative 2 Joint Undertaking
  • European Union’s Horizon 2020 Research and Innovation Program
  • National Research, Development and Innovation Office, Hungary

Zitieren

APA

Hudák, A., Roach, M., Pusztai, D., Pettkó-Szandtner, A., Letoha, A., Szilák, L., Azzouz, M., & Letoha, T. (2023). Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043141

Vancouver

Hudák A, Roach M, Pusztai D, Pettkó-Szandtner A, Letoha A, Szilák L, et al. Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043141

BibTeX
@article{Hudk2023,
  author = {Hudák, Anett and Roach, Matthew and Pusztai, Dávid and Pettkó-Szandtner, Aladár and Letoha, Annamária and Szilák, László and Azzouz, Mimoun and Letoha, Tamás},
  title = {Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043141}
}
Kostenlos starten →